{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:11:36Z","timestamp":1770473496089,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"KNUST Research Fund","award":["VC\/OGR\/15"],"award-info":[{"award-number":["VC\/OGR\/15"]}]},{"name":"KNUST Research Fund","award":["VC\/OGR\/15"],"award-info":[{"award-number":["VC\/OGR\/15"]}]},{"name":"KNUST Research Fund","award":["VC\/OGR\/15"],"award-info":[{"award-number":["VC\/OGR\/15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14893-4","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:39:33Z","timestamp":1760085573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of zinc and testosterone co-treatment on tumourigenesis in prostate cancer: a novel model"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-0730","authenticated-orcid":false,"given":"Kofi Oduro","family":"Yeboah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3228-4741","authenticated-orcid":false,"given":"Paul","family":"Atawuchugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9231-4012","authenticated-orcid":false,"given":"Fredrick Kwadwo","family":"Baah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7921-0642","authenticated-orcid":false,"given":"Bernard Elikplim","family":"Petershie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1746-0854","authenticated-orcid":false,"given":"Yolanda","family":"Ashie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5723-7266","authenticated-orcid":false,"given":"Eric","family":"Boakye-Gyasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-2368","authenticated-orcid":false,"given":"Newman","family":"Osafo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8003-1127","authenticated-orcid":false,"given":"Emmanuel Amankwah","family":"Ntim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-785X","authenticated-orcid":false,"given":"George","family":"Ainooson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"17","key":"14893_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174212","volume":"15","author":"MK Thomsen","year":"2023","unstructured":"Thomsen MK, Busk M. Pre-clinical models to study human prostate cancer. Cancers (Basel). 2023;15(17): 4212. https:\/\/doi.org\/10.3390\/cancers15174212.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"14893_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/life12101607","volume":"12","author":"D Basak","year":"2022","unstructured":"Basak D, Gregori L, Johora F, Deb S. Preclinical and clinical research models of prostate cancer: a brief overview. Life. 2022;12(10): 1607. https:\/\/doi.org\/10.3390\/life12101607.","journal-title":"Life"},{"issue":"1","key":"14893_CR3","doi-asserted-by":"publisher","first-page":"11117","DOI":"10.1038\/s41598-019-47308-z","volume":"9","author":"W Zhang","year":"2019","unstructured":"Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC. Comparative study of subcutaneous and orthotopic mouse models of prostate cancer: vascular perfusion, vasculature density, hypoxic burden and BB2r-targeting efficacy. Sci Rep. 2019;9(1):11117. https:\/\/doi.org\/10.1038\/s41598-019-47308-z.","journal-title":"Sci Rep"},{"issue":"21","key":"14893_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215321","volume":"14","author":"R Adamiecki","year":"2022","unstructured":"Adamiecki R, Hryniewicz-Jankowska A, Ortiz MA, et al. In vivo models for prostate cancer research. Cancers (Basel). 2022;14(21): 5321. https:\/\/doi.org\/10.3390\/cancers14215321.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"14893_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.21873\/anticanres.16167","volume":"43","author":"AI Faustino-Rocha","year":"2023","unstructured":"Faustino-Rocha AI, Jota-Baptista C, Nascimento-Gon\u00e7alves E, Oliveira PA. Evolution of models of prostate cancer: their contribution to current therapies. Anticancer Res. 2023;43(1):323\u201333. https:\/\/doi.org\/10.21873\/anticanres.16167.","journal-title":"Anticancer Res"},{"issue":"2","key":"14893_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/aja.2009.74","volume":"12","author":"YH Ko","year":"2010","unstructured":"Ko YH, Woo YJ, Kim JW, et al. High-dose dietary zinc promotes prostate intraepithelial neoplasia in a murine tumor induction model. Asian J Androl. 2010;12(2):164\u201370. https:\/\/doi.org\/10.1038\/aja.2009.74.","journal-title":"Asian J Androl"},{"issue":"3","key":"14893_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3945\/ajcn.110.004804","volume":"93","author":"MM Epstein","year":"2011","unstructured":"Epstein MM, Kasperzyk JL, Andr\u00e9n O, et al. Dietary zinc and prostate cancer survival in a Swedish cohort. Am J Clin Nutr. 2011;93(3):586\u201393. https:\/\/doi.org\/10.3945\/ajcn.110.004804.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"14893_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/pros.22565","volume":"73","author":"SY Park","year":"2013","unstructured":"Park SY, Wilkens LR, Morris JS, Henderson BE, Kolonel LN. Serum zinc and prostate cancer risk in a nested case-control study: the multiethnic cohort. Prostate. 2013;73(3):261\u20136. https:\/\/doi.org\/10.1002\/pros.22565.","journal-title":"Prostate"},{"issue":"11","key":"14893_CR9","doi-asserted-by":"publisher","first-page":"e0165956","DOI":"10.1371\/journal.pone.0165956","volume":"11","author":"AM Mahmoud","year":"2016","unstructured":"Mahmoud AM, Al-Alem U, Dabbous F, et al. Zinc intake and risk of prostate cancer: case-control study and meta-analysis. PLoS One. 2016;11(11):e0165956. https:\/\/doi.org\/10.1371\/journal.pone.0165956.","journal-title":"PLoS One"},{"issue":"12","key":"14893_CR10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s10654-022-00922-0","volume":"37","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Song M, Mucci LA, Giovannucci EL. Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study. Eur J Epidemiol. 2022;37(12):1251\u201360. https:\/\/doi.org\/10.1007\/s10654-022-00922-0.","journal-title":"Eur J Epidemiol"},{"issue":"13","key":"14893_CR11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/jnci\/95.13.1004","volume":"95","author":"MF Leitzmann","year":"2003","unstructured":"Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst. 2003;95(13):1004\u20137. https:\/\/doi.org\/10.1093\/jnci\/95.13.1004.","journal-title":"J Natl Cancer Inst"},{"key":"14893_CR12","doi-asserted-by":"publisher","unstructured":"Murray TBJ. (2021). The Pathogenesis of Prostate Cancer. In: Bott SRJ, Ng KL, editors. Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021. Chapter 3. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK571321\/https:\/\/doi.org\/10.36255\/exonpublications.prostatecancer.pathogenesis.2021","DOI":"10.36255\/exonpublications.prostatecancer.pathogenesis.2021"},{"issue":"4","key":"14893_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3322\/canjclin.22.4.232","volume":"22","author":"C Huggins","year":"1972","unstructured":"Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of Estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin. 1972;22(4):232\u201340. https:\/\/doi.org\/10.3322\/canjclin.22.4.232.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"14893_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703.","journal-title":"J Basic Clin Pharm"},{"issue":"21","key":"14893_CR15","first-page":"4687","volume":"57","author":"JR Gingrich","year":"1997","unstructured":"Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res. 1997;57(21):4687\u201391.","journal-title":"Cancer Res"},{"issue":"670","key":"14893_CR16","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.3399\/bjgp18X695801","volume":"68","author":"BD Nicholson","year":"2018","unstructured":"Nicholson BD, Hamilton W, O\u2019Sullivan J, Aveyard P, Hobbs FR. Weight loss as a predictor of cancer in primary care: a systematic review and meta-analysis. BJGP. 2018;68(670):e311\u201322. https:\/\/doi.org\/10.3399\/bjgp18X695801.","journal-title":"BJGP"},{"key":"14893_CR17","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.2147\/CMAR.S261585","volume":"12","author":"J Ni","year":"2020","unstructured":"Ni J, Zhang L. Cancer cachexia. Definition, staging, and emerging treatments. Cancer Manag Res. 2020;12:5597\u2013605. https:\/\/doi.org\/10.2147\/CMAR.S261585.","journal-title":"Cancer Manag Res"},{"key":"14893_CR18","doi-asserted-by":"publisher","unstructured":"Dewys WD, Begg C, Lavin PT, Eastern cooperative oncology group, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980;69(4):491\u20137. https:\/\/doi.org\/10.1016\/s0149-2918(05)80001-3.","DOI":"10.1016\/s0149-2918(05)80001-3."},{"issue":"2","key":"14893_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/advances\/nmz084","volume":"11","author":"S Abdollahi","year":"2020","unstructured":"Abdollahi S, Toupchian O, Jayedi A, Meyre D, Tam V, Soltani S. Zinc supplementation and body weight: a systematic review and dose-response meta-analysis of randomized controlled trials. Adv Nutr. 2020;11(2):398\u2013411. https:\/\/doi.org\/10.1093\/advances\/nmz084.","journal-title":"Adv Nutr"},{"issue":"14","key":"14893_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411634","volume":"24","author":"J Hata","year":"2023","unstructured":"Hata J, Harigane Y, Matsuoka K, et al. Mechanism of androgen-independent stromal proliferation in benign prostatic hyperplasia. Int J Mol Sci. 2023;24(14): 11634. https:\/\/doi.org\/10.3390\/ijms241411634.","journal-title":"Int J Mol Sci"},{"key":"14893_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01293","volume":"10","author":"AK Sauer","year":"2020","unstructured":"Sauer AK, Vela H, Vela G, Stark P, Barrera-Juarez E, Grabrucker AM. Zinc deficiency in men over 50 and its implications in prostate disorders. Front Oncol. 2020;10: 1293. https:\/\/doi.org\/10.3389\/fonc.2020.01293.","journal-title":"Front Oncol"},{"issue":"3","key":"14893_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.20892\/j.issn.2095-3941.2020.0106","volume":"17","author":"J Wang","year":"2020","unstructured":"Wang J, Zhao H, Xu Z, Cheng X. Zinc dysregulation in cancers and its potential as a therapeutic target. Cancer Biol Med. 2020;17(3):612\u201325. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0106.","journal-title":"Cancer Biol Med"},{"issue":"8","key":"14893_CR23","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/ijms21082991","volume":"21","author":"T PK","year":"2020","unstructured":"PK T, Do MH, Cho JH, Jung C. Growth modulatory role of zinc in prostate cancer and application to cancer therapeutics. Int J Mol Sci. 2020;21(8):2991. https:\/\/doi.org\/10.3390\/ijms21082991.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"14893_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrc2795","volume":"10","author":"GP Risbridger","year":"2010","unstructured":"Risbridger GP, Davis ID, Birrell SN, Tilley WD. Breast and prostate cancer: more similar than different. Nat Rev Cancer. 2010;10(3):205\u201312. https:\/\/doi.org\/10.1038\/nrc2795.","journal-title":"Nat Rev Cancer"},{"key":"14893_CR25","unstructured":"Leslie SW, Soon-Sutton TL, Skelton WP. Prostate Cancer. [Updated 2024 Oct 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470550\/"},{"issue":"S1","key":"14893_CR26","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1038\/modpathol.2017.138","volume":"31","author":"M Zhou","year":"2018","unstructured":"Zhou M. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate. Mod Pathol. 2018;31(S1):S71\u20139. https:\/\/doi.org\/10.1038\/modpathol.2017.138.","journal-title":"Mod Pathol"},{"issue":"4","key":"14893_CR27","doi-asserted-by":"publisher","first-page":"a030403","DOI":"10.1101\/cshperspect.a030403","volume":"9","author":"L Trabzonlu","year":"2019","unstructured":"Trabzonlu L, Kulac I, Zheng Q, Hicks JL, Haffner MC, Nelson WG, Sfanos KS, Ertunc O, Lotan TL, Heaphy CM, Meeker AK, Yegnasubramanian S, De Marzo AM. Molecular pathology of high-grade prostatic intraepithelial neoplasia: challenges and opportunities. Cold Spring Harb Perspect Med. 2019;9(4):a030403. https:\/\/doi.org\/10.1101\/cshperspect.a030403.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"14893_CR28","doi-asserted-by":"publisher","first-page":"MRI","DOI":"10.4137\/MRI.S602","volume":"4","author":"K Stenman","year":"2010","unstructured":"Stenman K, Surowiec I, Antti H, Riklun K, Stattin P, Bergh A, Gr\u00f6bner G. Detection of local prostate metabolites by HRMAS NMR spectroscopy: A comparative study of human and rat prostate tissues. Magn Reson Insights. 2010;4:MRI\u2013S6028. https:\/\/doi.org\/10.4137\/MRI.S602.","journal-title":"Magn Reson Insights"},{"issue":"17","key":"14893_CR29","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730. https:\/\/doi.org\/10.3390\/molecules27175730.","journal-title":"Molecules"},{"issue":"4","key":"14893_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4103\/1008-682X.168793","volume":"18","author":"LE Pascal","year":"2016","unstructured":"Pascal LE, Wang Z. Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations. Asian J Androl. 2016;18(4):594\u20135. https:\/\/doi.org\/10.4103\/1008-682X.168793.","journal-title":"Asian J Androl"},{"issue":"1","key":"14893_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep43378","volume":"7","author":"Y Nordby","year":"2017","unstructured":"Nordby Y, Richardsen E, Rakaee M, Ness N, Donnem T, Patel HR, Busund LT, Bremnes RM, Andersen S. High expression of PDGFR-\u03b2 in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Sci Rep. 2017;7(1): 43378. https:\/\/doi.org\/10.1038\/srep43378.","journal-title":"Sci Rep"},{"key":"14893_CR32","doi-asserted-by":"publisher","first-page":"623809","DOI":"10.3389\/fcell.2021.623809","volume":"9","author":"M Scaravilli","year":"2021","unstructured":"Scaravilli M, Koivukoski S, Latonen L. Androgen-driven fusion genes and chimeric transcripts in prostate cancer. Front Cell Dev Biol. 2021;9:623809. https:\/\/doi.org\/10.3389\/fcell.2021.623809.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"14893_CR33","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1158\/2159-8290.CD-13-0873","volume":"4","author":"YR Chin","year":"2014","unstructured":"Chin YR, Yuan X, Balk SP, Toker A. PTEN-deficient tumors depend on AKT2 for maintenance and survival. Cancer Discov. 2014;4(8):942\u201355. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0873.","journal-title":"Cancer Discov"},{"issue":"29","key":"14893_CR34","doi-asserted-by":"publisher","first-page":"27097","DOI":"10.18632\/oncotarget.4553","volume":"6","author":"HP Lin","year":"2015","unstructured":"Lin HP, Lin CY, Huo C, Jan YJ, Tseng JC, Jiang SS, et al. AKT3 promotes prostate cancer proliferation cells through regulation of akt, B-Raf, and TSC1\/TSC2. Oncotarget. 2015;6(29):27097\u2013112. https:\/\/doi.org\/10.18632\/oncotarget.4553.","journal-title":"Oncotarget"},{"issue":"6","key":"14893_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1158\/2326-6066.CIR-21-0587","volume":"10","author":"SS Dinavahi","year":"2022","unstructured":"Dinavahi SS, Chen YC, Punnath K, Berg A, Herlyn M, Foroutan M, et al. Argeting WEE1\/AKT restores p53-dependent natural killer-cell activation to induce immune checkpoint blockade responses in cold melanoma. Cancer Immunol Res. 2022;10(6):757\u201369. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0587.","journal-title":"Cancer Immunol Res"},{"key":"14893_CR36","doi-asserted-by":"publisher","unstructured":"Teroerde M, Nientiedt C, Duensing A et al. Revisiting the Role of p53 in Prostate Cancer. In: Bott SRJ, Ng KL, editors. Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021. Chapter 8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK571319\/https:\/\/doi.org\/10.36255\/exonpublications.prostatecancer.p53.2021","DOI":"10.36255\/exonpublications.prostatecancer.p53.2021"},{"key":"14893_CR37","doi-asserted-by":"publisher","first-page":"e37868","DOI":"10.7554\/eLife.37868","volume":"7","author":"B Benedict","year":"2018","unstructured":"Benedict B, van Harn T, Dekker M, Hermsen S, Kucukosmanoglu A, Pieters W, et al. Loss of p53 suppresses replication-stress-induced DNA breakage in G1\/S checkpoint deficient cells. Elife. 2018;7:e37868. https:\/\/doi.org\/10.7554\/eLife.37868.","journal-title":"Elife"},{"issue":"8","key":"14893_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","volume":"20","author":"AJ Levine","year":"2020","unstructured":"Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer. 2020;20(8):471\u201380. https:\/\/doi.org\/10.1038\/s41568-020-0262-1.","journal-title":"Nat Rev Cancer"},{"issue":"5\u20136","key":"14893_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00335-019-09798-0","volume":"30","author":"ALD Tadenev","year":"2019","unstructured":"Tadenev ALD, Burgess RW. Model validity for preclinical studies in precision medicine: precisely how precise do we need to be? Mamm Genome. 2019;30(5\u20136):111\u201322. https:\/\/doi.org\/10.1007\/s00335-019-09798-0.","journal-title":"Mamm Genome"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14893-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14893-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14893-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T12:27:19Z","timestamp":1760358439000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14893-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14893"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14893-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The department review board on the use of animals for experimental purposes, the Department of Pharmacology Animal Research Ethics Committee (DPAREC) of KNUST, Ghana approved (Approval No: PCOL\/23\/016) all the protocols used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1552"}}